by InfluencER | Feb 10, 2021 | Pharma
Canadian cannabis producer Canopy Growth says its business transformation is taking shape despite an 829.3 million Canadian dollar ($651 million) net loss for the third quarter of its 2021 fiscal year, which ended Dec. 31. Among other new financial targets, the Smiths...
by InfluencER | Feb 9, 2021 | Pharma
Tilray stock headed for its second straight day of explosive gains Tuesday after the pot grower announced a deal to ship medical marijuana to Britain. The Canadian company’s shares surged about 20 percent in premarket trading to $36.25 as of 8:02 a.m. on news of its...
by InfluencER | Feb 5, 2021 | Pharma
Jazz Pharmaceuticals’ planned $7.2 billion takeovers of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis producers benefiting,...
by InfluencER | Feb 5, 2021 | Pharma
Tilray, Inc., a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has received the necessary approvals and market authorization in accordance with the Portuguese legislation to offer Tilray medical cannabis products in...
by InfluencER | Feb 4, 2021 | Pharma
A British scientist dubbed ‘Dr. Pot’ and his business partner was last night celebrating a £94million windfall after selling their cannabis firm for £5.3billion. Dr. Geoffrey Guy founded Cambridge-based GW Pharmaceuticals in 1998 but is selling the company to Irish...
by InfluencER | Feb 4, 2021 | Pharma
Jazz Pharmaceuticals Plc said on Wednesday it would buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal to bolster its neuroscience business by adding a cannabis-based epilepsy treatment.GW Pharma’s Epidiolex is the first marijuana-derived drug that was...
